Comparison

Lenvatinib mesylate European Partner

€56.00
Excl. VAT
Item no. TMO-T8541-25mg
Manufacturer TargetMol
CASRN 857890-39-2
Amount 25mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles CS(O)(=O)=O.COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 857890-39-2, E7080 (mesylate)
Available
Short Description
Lenvatinib mesylate is an oral and multi-targeted inhibitor of VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, with potent antitumor activities.
Shipping
cool pack
Storage
-20°
Target names or alias
E7080 (mesylate)
Molecular Weight
522, 96
Pathway
Apoptosis|||Angiogenesis|||Tyrosine Kinase/Adaptors
Target
c-RET|||VEGFR|||PDGFR|||c-Kit|||FGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
Listprice: €56.00
Price: €56.00
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close